American Journal of Cardiology
Volume 99, Issue 2 , Pages 186-188, 15 January 2007

Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome

  • Sanjit Jolly, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Mary Tan

      Affiliations

    • Canadian Heart Research Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Aurora Mendelsohn

      Affiliations

    • Canadian Heart Research Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • David Fitchett, MD

      Affiliations

    • Canadian Heart Research Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Paul W. Armstrong, MD

      Affiliations

    • Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
    • ,
  • Anatoly Langer, MD

      Affiliations

    • Canadian Heart Research Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Shaun G. Goodman, MD

      Affiliations

    • Canadian Heart Research Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St. Michaelx2019;s Hospital, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author: Tel: 416-864-5722; fax: 416-864-5407.

Received 15 February 2006; received in revised form 25 July 2006; accepted 25 July 2006. published online 17 November 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The ESSENCE study and ESSENCE ECG substudy were sponsored by Aventis Pharma, USA. The INTERACT study was sponsored by the Canadian Heart Research Centre, Toronto, Ontario, Canada; Key Pharmaceuticals, Division of Schering Canada, Inc., Kirkland, Quebec, Canada; and Millienium Pharmaceuticals, Inc., Cambridge, Massachusetts.

PII: S0002-9149(06)01996-5

doi:10.1016/j.amjcard.2006.07.078

American Journal of Cardiology
Volume 99, Issue 2 , Pages 186-188, 15 January 2007

Article Tools